International Journal of Drug Policy

Article	Citations
The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis	334
Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets	103
An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples	95
Tackling the overdose crisis: The role of safe supply	95
“Everything is not right anymore”: Buprenorphine experiences in an era of illicit fentanyl	78
Evaluating the impacts of cannabis legalization: The International Cannabis Policy Study	74
Safer opioid distribution in response to the COVID-19 pandemic	68
Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada	67
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada	67
Syringe services program (SSP) operational changes during the COVID-19 global outbreak	63
COVID-19 and the health of people who use drugs: What is and what could be?	63
Policing space in the overdose crisis: A rapid ethnographic study of the impact of law enforcement practices on the effectiveness of overdose prevention sites	61
Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?	57
The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysis	57
Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: A case study of the rural risk environment in Appalachian Kentucky	54
Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs	53
Ambiguous identities of drugs and people: A scoping review of opioid-related stigma	53
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update	53
Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston	52
Opioid-related deaths in Europe: Strategies for a comprehensive approach to address a major public health concern	51
The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England	50
Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19	50
A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System	49
“We don’t got that kind of time, man. We’re trying to get high!”: Exploring potential use of drug checking technologies among structurally vulnerable people who use drugs	48
An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods	47

Integrated models of care for people who inject drugs and live with hepatitis C virus: A systematic review	47
Communicating THC levels and ‘dose’ to consumers: Implications for product labelling and packaging of cannabis products in regulated markets	45
“They're making it so hard for people to get help:” Motivations for non-prescribed buprenorphine use in a time of treatment expansion	44
COVID-19 - Enacting a ‘new normal’ for people who use drugs	44
Comparing Canadian and United States opioid agonist therapy policies	43
Prescription drug monitoring programs operational characteristics and fatal heroin poisoning	43
Access to cannabidiol without a prescription: A cross-country comparison and analysis	42
Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019”	42
“You are not clean until you're not on anything”: Perceptions of medication-assisted treatment in rural Appalachia	42
Multi-level drivers of tobacco use and purchasing behaviors during COVID-19 “lockdown”: A qualitative study in the United States	41
Care during COVID-19: Drug use, harm reduction, and intimacy during a global pandemic	41
The value of unsolicited online data in drug policy research	41
‘It's too much, I'm getting really tired of it’: Overdose response and structural vulnerabilities among harm reduction workers in community settings	41
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences	40
Street fentanyl use: Experiences, preferences, and concordance between self-reports and urine toxicology	40
Doing ontopolitically-oriented research: Synthesising concepts from the ontological turn for alcohol and other drug research and other social sciences	39
Cigarette, smokeless tobacco, and alcohol use among transgender adults in the United States	38
Microdosing psychedelics: Motivations, subjective effects and harm reduction	37
The epidemiology of drug use disorders cross-nationally: Findings from the WHO’s World Mental Health Surveys	37
A rapid review of the impacts of “Big Events ” on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19	36
Known fentanyl use among clients of harm reduction sites in British Columbia, Canada	36
Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all	36
Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study	35
Evaluation of a drug checking service at a large scale electronic music festival in Portugal	35
Chronic pain management among people who use drugs: A health policy challenge in the context of the opioid crisis	35
Outcomes of a nurse-led model of care for hepatitis C assessment and treatment with direct-acting antivirals in the custodial setting	35
Changes in characteristics of drug overdose death trends during the COVID-19 pandemic	35
‘It's our safe sanctuary’: Experiences of using an unsanctioned overdose prevention site in Toronto, Ontario	35
Barriers to naloxone use and acceptance among opioid users, first responders, and emergency department providers in New Hampshire, USA	35
Destabilising the ‘problem’ of chemsex: Diversity in settings, relations and practices revealed in Australian gay and bisexual men's crystal methamphetamine use	35
Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-19	35
Agency in the fentanyl era: Exploring the utility of fentanyl test strips in an opaque drug market	34
Conceptualising access in the direct-acting antiviral era: An integrated framework to inform research and practice in HCV care for people who inject drugs	34
Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugs	34
Adverse drug-related effects among electronic dance music party attendees	34
“That's why people don't call 911”: Ending routine police attendance at drug overdoses	34
Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework	34
“How will I get my next week's script?” Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic	33
Drugs as technologies of the self: Enhancement and transformation in LGBTQ cultures	33
Intersectional structural vulnerability to abusive policing among people who inject drugs: A mixed methods assessment in California's central valley	32
Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis	32
Time matters: Point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England	32
From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic	32
Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programs	31
Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, Spain	31
Legal and policy changes urgently needed to increase access to opioid agonist therapy in the United States	31
Quantitative evaluation of an integrated nurse model of care providing hepatitis C treatment to people attending homeless services in Melbourne, Australia	31
Increased risk of HIV and other drug-related harms associated with injecting in public places: national bio-behavioural survey of people who inject drugs	31
Sellers’ risk perceptions in public and private social media drug markets	30
Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone	30

A narrative systematic review of sexualised drug use and sexual health outcomes among LGBT people	29
Women's utilization of housing-based overdose prevention sites in Vancouver, Canada: An ethnographic study	29
Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participants	28
Intentions, actions and outcomes: A follow up survey on harm reduction practices after using an English festival drug checking service	28
Making sense of ‘side effects’: Counterpublic health in the era of direct-acting antivirals	28
Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada	28
Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs	28
“Bed Bugs and Beyond”: An ethnographic analysis of North America's first women-only supervised drug consumption site	27
Delineation of chemsex patterns of men who have sex with men in association with their sexual networks and linkage to HIV prevention	27
Life projects: the transformative potential of direct-acting antiviral treatment for hepatitis C among people who inject drugs	27
Cost-effectiveness analysis of alternative naloxone distribution strategies: First responder and lay distribution in the United States	27
I don't even want to go to the doctor when I get sick now: Healthcare experiences and discrimination reported by people who use drugs, Arizona 2019	26
Experiences with substance use disorder treatment during the COVID-19 pandemic: Findings from a multistate survey	26
“It's like super structural” – Overdose experiences of youth who use drugs and police in three non-metropolitan cities across British Columbia	26
Implementing harm reduction in non-urban communities affected by opioids and polysubstance use: A qualitative study exploring challenges and mitigating strategies	26
High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction units	26
Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic	26
Engagement with medical cannabis information from online and mass media sources: Is it related to medical cannabis attitudes and support for legalization?	25
Overdose among mothers: The association between child removal and unintentional drug overdose in a longitudinal cohort of marginalised women in Canada	25
Prevalence, frequency, and motivations for alkyl nitrite use among gay, bisexual and other men who have sex with men in Australia	25
Rural risk environments for hepatitis c among young adults in appalachian kentucky	25
Framing and scientific uncertainty in nicotine vaping product regulation: An examination of competing narratives among health and medical organisations in the UK, Australia and New Zealand	25
Police-related barriers to harm reduction linked to non-fatal overdose amongst sex workers who use drugs: Results of a community-based cohort in Metro Vancouver, Canada	25
Attitudes toward legalization of marijuana in the United States, 1986-2016: Changes in determinants of public opinion	25
The perfect storm: COVID-19, mass incarceration and the opioid epidemic	25
Housing in crisis: A qualitative study of the socio-legal contexts of residential evictions in Vancouver’s Downtown Eastside	25
Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: A latent class analysis	25
Impact of Hepatitis C treatment on behavioural change in relation to drug use in people who inject drugs: A systematic review	25
The protective effect of trusted dealers against opioid overdose in the U.S.	25
The impact of cannabis legalization in Uruguay on adolescent cannabis use	25
Race, cannabis and the Canadian war on drugs: An examination of cannabis arrest data by race in five cities	25
Harm reduction in the time of COVID-19: Case study of homelessness and drug use in Dublin, Ireland	25
International differences in patterns of cannabis use among adult cigarette smokers: Findings from the 2018 ITC Four Country Smoking and Vaping Survey	25
Rural risk environments, opioid-related overdose, and infectious diseases: A multidimensional, spatial perspective	24
Is South Africa being spared the global opioid crisis? A review of trends in drug treatment demand for heroin, nyaope and codeine-related medicines in South Africa (2012–2017)	24
An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE study	24
Recent fentanyl use among people who inject drugs: Results from a rapid assessment in Baltimore, Maryland	24
Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama	24
Co-use of methamphetamine and opioids among people in treatment in Oregon: A qualitative examination of interrelated structural, community, and individual-level factors	24
No “back to normal” after COVID-19 for our failed drug policies	24
Anabolic-androgenic steroid use among women – A qualitative study on experiences of masculinizing, gonadal and sexual effects	24
The Bell Tolls for Thee & Thine: Compassion Fatigue & the Overdose Epidemic	24
Injecting drug use during sex (known as “slamming”) among men who have sex with men: Results from a time-location sampling survey conducted in five cities, France	24
Re-configured pleasures: How young people feel good through abstaining or moderating their drinking	23
Price and product variation in Washington's recreational cannabis market	23
Peer outreach point-of-care testing as a bridge to hepatitis C care for people who inject drugs in Toronto, Canada	23
A qualitative study of e-cigarette emergence and the potential for renormalisation of smoking in UK youth	23
Correlates of seeking emergency medical help in the event of an overdose in British Columbia, Canada: Findings from the Take Home Naloxone program	23
An urgent impetus for action: safe inhalation interventions to reduce COVID-19 transmission and fatality risk among people who smoke crack cocaine in the United Kingdom	23
Trajectories of retention in opioid agonist therapy in a Canadian setting	23
Subgroup trends in alcohol and cannabis co-use and related harms during the rollout of recreational cannabis legalization in Washington state	23
Social media surveillance for perceived therapeutic effects of cannabidiol (CBD) products	23
“I couldn't live with killing one of my friends or anybody”: A rapid ethnographic study of drug sellers’ use of drug checking	23
When does the cutting of cocaine and heroin occur? The first large-scale study based on the chemical analysis of cocaine and heroin seizures in Switzerland	22
Divergences and commonalities between the US opioid crisis and prescription medicine mis/use in West Africa	22
Stigma, discrimination and crystal methamphetamine (‘ice’): Current attitudes in Australia	22
Developing interagency collaboration to address the opioid epidemic: A scoping review of joint criminal justice and healthcare initiatives	22
HCV testing and treatment initiation in an Italian prison setting: A step-by-step model to micro-eliminate hepatitis C	22
Public interest in ∆8-Tetrahydrocannabinol (delta-8-THC) increased in US states that restricted ∆9-Tetrahydrocannabinol (delta-9-THC) use	22
Trends in the use of cannabis products in Canada and the USA, 2018 – 2020: Findings from the International Cannabis Policy Study	22
Adulterants and altruism: A qualitative investigation of “drug checkers” in North America	22
“It's an emotional roller coaster… But sometimes it's fucking awesome”: Meaning and motivation of work for peers in overdose response environments in British Columbia	22
Utility of a one-step screening and diagnosis strategy for viremic HCV infection among people who inject drugs in Catalonia	22
MDMA-related deaths in Australia 2000 to 2018	22
People, places, and stigma: A qualitative study exploring the overdose risk environment in rural Kentucky	22
‘Peer’ work as precarious: A qualitative study of work conditions and experiences of people who use drugs engaged in harm reduction work	22
Telemedicine efficiently improves access to hepatitis C management to achieve HCV elimination in the penitentiary setting	21
The internet market for Kratom, an opioid alternative and variably legal recreational drug	21
Drugs and drug wars as populist tropes in Asia: Illustrative examples and implications for drug policy	21
Preliminary findings of the impact of COVID-19 on drugs crypto markets	21
Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets	21
The impacts of potency, warning messages, and price on preferences for Cannabis flower products	21
How high: Differences in the developments of cannabis markets in two legalized states	21
Nonmedical prescription psychiatric drug use and the darknet: A cryptomarket analysis	21
Lower HCV treatment uptake in women who have received opioid agonist therapy before and during the DAA era: The ANRS FANTASIO project	21
Drugs, discipline and death: Causes and predictors of mortality among people who inject drugs in Tijuana, 2011–2018	21
The impact of rurality on opioid-related harms: A systematic review of qualitative research	21
Fentanyl behind bars: The implications of synthetic opiates for prisoners and correctional officers	21
Changes in alcohol and cigarette consumption in response to medical and recreational cannabis legalization: Evidence from U.S. state tax receipt data	20
Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids	20

Government monopoly as an instrument for public health and welfare: Lessons for cannabis from experience with alcohol monopolies	20
Good Samaritan laws and overdose mortality in the United States in the fentanyl era	20
“I probably got a minute”: Perceptions of fentanyl test strip use among people who use stimulants	20
Perceptions of effectiveness and believability of pictorial and text-only health warning labels for cannabis products among Canadian youth	20
Content analysis of online product descriptions from cannabis retailers in six US states	20
The Dark Web and cannabis use in the United States: Evidence from a big data research design	20
Changes in Australian prescription opioid use following codeine rescheduling: A retrospective study using pharmaceutical benefits data	20
Drug use during a pandemic: Convergent risk of novel coronavirus and invasive bacterial and viral infections among people who use drugs	20
Cannabis sales increases during COVID-19: Findings from Alaska, Colorado, Oregon, and Washington	19
Producing the vulnerable subject in English drug policy	19
Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs?	19
Fentanyl panic goes viral: The spread of misinformation about overdose risk from casual contact with fentanyl in mainstream and social media	19
No magic pocket: Buying and selling on drug cryptomarkets in response to the COVID-19 pandemic and social restrictions	19
The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs	19
“Doing What Is Right and Doing It Right”: A Mapping Review of Athletes' Perception of Anti-Doping Legitimacy	19
Portable gas chromatography–mass spectrometry in drug checking: Detection of carfentanil and etizolam in expected opioid samples	19
Patterns, contexts, and motivations for polysubstance use among people who inject drugs in non-urban settings in the U.S. Northeast	19
Alcohol policy has saved lives in the Russian Federation	19
Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department	19
Digital chemsex support and care: The potential of just-in-time adaptive interventions	19
Conceptualising hepatitis C stigma: A thematic synthesis of qualitative research	19
Pleasure and HIV biomedical discourse: The structuring of sexual and drug-related risks for gay and bisexual men who Party-n-Play	19
Tough Tradeoffs: Coca crops and agrarian alternatives in Colombia	18
The effectiveness of drug-related Good Samaritan laws: A review of the literature	18
Individual and network factors associated with HCV treatment uptake among people who inject drugs	18
Peer-delivered services for substance use in low- and middle-income countries: A systematic review	18
“Everybody living with a chronic disease is entitled to be cured”: Challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drug	18
Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services	18
Triangulating web & general population surveys: Do results match legal cannabis market sales?	18
Legal cannabis market shares during Canada's first year of recreational legalisation	18
Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minima	18
Intensity of cannabis use: Findings from three online surveys	18
Rapid and accurate etizolam detection using surface-enhanced Raman spectroscopy for community drug checking	18
‘Pretty in Pink’ and ‘Girl Power’: An analysis of the targeting and representation of women in alcohol brand marketing on Facebook and Instagram	18
Receiving addiction treatment in the US: Do patient demographics, drug of choice, or substance use disorder severity matter?	18
One “chemsex” or many? Types of chemsex sessions among gay and other men who have sex with men in Madrid, Spain: findings from a qualitative study	17
Methadone exposures reported to poison control centers in the United States following the COVID-19-related loosening of federal methadone regulations	17
Enacting ‘more-than-human’ care: Clients’ and counsellors’ views on the multiple affordances of chatbots in alcohol and other drug counselling	17
Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market	17
Between gang talk and prohibition: The transfer of blame for County Lines	17
Virtual raves and happy hours during COVID-19: New drug use contexts for electronic dance music partygoers	17
“Towards eliminating viral hepatitis”: Examining the productive capacity and constitutive effects of global policy on hepatitis C elimination	17
“Another thing to live for”: Supporting HCV treatment and cure among Indigenous people impacted by substance use in Canadian cities	17
Help me fix: The provision of injection assistance at an unsanctioned overdose prevention site in Toronto, Canada	17
Alcohol consumption and attributable harm in middle-income South-East Asian countries: Epidemiology and policy options	17
Digital figurations in the online trade of illicit drugs: A qualitative content analysis of darknet forums	17
Direct-acting antiviral treatment for hepatitis C, reinfection and mortality among people attending an inner-city community health centre in Victoria, Canada	17
Message framing to reduce stigma and increase support for policies to improve the wellbeing of people with prior drug convictions	17
Legitimizing and negotiating abstinence: Young adults’ narratives about practicing situational and long term abstinence in Denmark.	17
Should we smoke it for you as well? An ethnographic analysis of a drug cryptomarket environment	17
Frequency of injecting among people who inject drugs: A systematic review and meta-analysis	17
Consumer protection in drug policy: The human rights case for safe supply as an element of harm reduction	17
Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence	17
Prevalence and correlates of carrying naloxone among a community-based sample of opioid-using people who inject drugs	16
‘It’s good being part of the community and doing the right thing’: (Re)problematising ‘community’ in new recovery-oriented policy and consumer accounts	16
A cost-effectiveness analysis of primary versus hospital-based specialist care for direct acting antiviral hepatitis C treatment	16
A systematic review of cigarette smoking trajectories in adolescents	16
“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Ca	16
Essential work, precarious labour: The need for safer and equitable harm reduction work in the era of COVID-19	16
Alcohol policy in Iran: Policy content analysis	16
Online surveillance of novel psychoactive substances (NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures	16
More-than-harm reduction: Engaging with alternative ontologies of ‘movement’ in UK drug services	15
Producing the ‘problem’ of new psychoactive substances (NPS) in English prisons	15
Contact tracing for hepatitis C: The case for novel screening strategies as we strive for viral elimination	15
Consumer discernment of fentanyl in illicit opioids confirmed by fentanyl test strips: Lessons from a syringe services program in North Carolina	15
Connections built and broken: The ontologies of relapse	15
What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada	15
The Pat Jasan drug eradication social movement in Northern Myanmar, part one: Origins & reactions	15
Testing the boundaries: Self-medicated testosterone replacement and why it is practised	15
“Stigma is where the harm comes from”: Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs	15
Principles, practice, and policy vacuums: Policy actor views on provincial/territorial harm reduction policy in Canada	15
Performance and image enhancing drug interventions aimed at increasing knowledge among healthcare professionals (HCP): reflections on the implementation of the Dopinglinkki e-module in Europe and Aust	15
We are the researched, the researchers, and the discounted: The experiences of drug user activists as researchers	15
Using the behaviour change wheel to understand and address barriers to pharmacy naloxone supply in Australia	15
Unity in diversity: A systematic review on the GHB using population	15
Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs	15
Can google trends search inform us about the population response and public health impact of abrupt change in alcohol policy? A case study from India during the covid-19 pandemic	15
Critical studies of harm reduction: Overdose response in uncertain political times	15
‘I feel like I have to become part of that identity’: Negotiating femininities and friendships through alcohol consumption in Newcastle, UK	15
The effect of cannabis laws on opioid use	15
Leveraging crowdsourcing methods to collect qualitative data in addiction science: Narratives of non-medical prescription opioid, heroin, and fentanyl use	15
Possibilities and pitfalls? Moderate drinking and alcohol abstinence at home since the COVID-19 lockdown	15
Growing pains: An overview of cannabis quality control and quality assurance in Canada	15
Extended lockdown and India’s alcohol policy: a qualitative analysis of newspaper articles	15
The fentanyl epidemic in Estonia: factors in its evolution and opportunities for a comprehensive public health response, a scoping review	15
The effects of the iPlayClean education programme on doping attitudes and susceptibility to use banned substances among high-level adolescent athletes from the UK: A cluster-randomised controlled tria	15
Substances detected in used syringes of injecting drug users across 7 cities in Europe in 2017 and 2018: The European Syringe Collection and Analysis Project Enterprise (ESCAPE)	15
‘Red Flags’ and ‘Red Tape’: Telehealth and pharmacy-level barriers to buprenorphine in the United States	15
Monitoring new psychoactive substances: Exploring the contribution of an online discussion forum	15
Refusal to accept emergency medical transport following opioid overdose, and conditions that may promote connections to care	14
Effects of strengthening alcohol labels on attention, message processing, and perceived effectiveness: A quasi-experimental study in Yukon, Canada	14
Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from a qualitative study	14
Sources of cannabis among young adults and associations with cannabis-related outcomes	14
Urban, individuals of color are impacted by fentanyl-contaminated heroin	14
A systematic review and meta-analysis of the prevalence of take-home naloxone (THN) ownership and carriage	14
Uruguayan Cannabis Social Clubs: From activism to dispensaries?	14
Alcohol and drinking within the lives of midlife women: A meta-study systematic review	14
Public support for alcohol control initiatives across seven countries	14
The pharmaceuticalisation of ‘healthy’ ageing: Testosterone enhancement for longevity	14
Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’ associated with naloxone supply	14
What is the face of new nicotine users? 2012–2018 e-cigarettes and tobacco use among young students in Italy	14
The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months	14
A systematic review of qualitative evidence on barriers to and facilitators of the implementation of opioid agonist treatment (OAT) programmes in prisons	14
Priorities and practices of risk reduction among gay and bisexual men in Australia who use crystal methamphetamine for sex	14
A qualitative study of a publicly funded pharmacy-dispensed naloxone program	14
Circumstances of overdose among street-involved, opioid-injecting women: Drug, set, and setting	14
Frequently asked questions about dabbing concentrates in online cannabis community discussion forums	14
The substitution program on trial: progress and setbacks of the peace agreement in the policy against illicit crops in Colombia	14
Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran	13
Factors associated with methamphetamine dependency among men who have sex with men engaging in chemsex: Findings from the COMeT study in Taiwan	13
Latent patterns of polysubstance use among people who use opioids: A systematic review	13
Understanding the reasons for using methamphetamine by sexual minority people in Dhaka, Bangladesh	13
Medical marijuana. What can we learn from the experiences in Canada, Germany and Thailand?	13
Lay knowledge and practices of methamphetamine use to manage opioid-related overdose risks	13
Rethinking enhancement substance use: A critical discourse studies approach	13
Reputation transferability across contexts: Maintaining cooperation among anonymous cryptomarket actors when moving between markets	13
Precarity, poverty and poppy: Encountering development in the uplands of Shan State, Myanmar	13
Isolating the isolated: Implications of COVID-19 quarantine measures on in-patient detoxification treatment for substance use disorders	13
Identifying opportunities for engaging the ‘community’ in local alcohol decision-making: A literature review and synthesis	13
The use of multi-national web surveys for comparative analysis: Lessons from the European Web Survey on Drugs	13
Critical realism and the ‘ontological politics of drug policy’	13
Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort	13
Associations between self-reported cannabis use frequency, potency, and cannabis/health metrics	13
Carfentanil on the darknet: Potential scam or alarming public health threat?	13
The United Kingdom's first unsanctioned overdose prevention site; A proof-of-concept evaluation	13
How medical are states’ medical cannabis policies?: Proposing a standardized scale	13
Beyond the narco frontier; rethinking an imaginary of the margins	13
Pharmacist dispensed naloxone: Knowledge, availability, participation and cost in selected California counties	13
The details of decriminalization: Designing a non-criminal response to the possession of drugs for personal use	13
“You don’t have to squirrel away in a staircase”: Patient motivations for attending a novel supervised drug consumption service in acute care	13
Structural competency in the post-prison period for people who inject drugs: A qualitative case study	13
Simple possession as a ‘tool’: Drug law enforcement practices among police officers in the context of depenalization in British Columbia, Canada	13
Illicit drug prices and quantity discounts: A comparison between a cryptomarket, social media, and police data	13
A policy mapping analysis of goals, target populations, and punitive notions in the U.S. congressional response to the opioid epidemic	12
A normalised future of addiction	12
“You can't go wrong being safe”: Motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs	12
#studydrugs–Persuasive posting on Instagram	12
Trends in cannabis use among U.S. adults amid the COVID-19 pandemic	12
Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis	12
Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients’ and prescribers’ experiences with changes in unsupervised dosing	12
Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence	12
Operational and contextual barriers to accessing supervised consumption services in two Canadian cities	12
Analytical findings in used syringes from a syringe exchange program	12
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis	12
The emergence of innovative cannabis distribution projects in the downtown eastside of Vancouver, Canada	12

Opioid overdose in the age of fentanyl: Risk factor differences among subpopulations of overdose survivors	12
Challenges of providing COVID-19 prevention services to homeless people who use drugs in Iran	12
Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic–Is an update of legal restrictions warranted?	12
Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada	12
‘Social health’, ‘physical health’, and well-being: Analysing with bourdieusian concepts the interplay between the practices of heavy drinking and exercise among young people	12
Examining the implementation of police-assisted referral programs for substance use disorder services in Massachusetts	12
How to think with models and targets: Hepatitis C elimination as a numbering performance	12
Investigating opioid preference to inform safe supply services: A cross sectional study	12
Drug overdose mortality among stateside Puerto Ricans: Evidence of a health disparity	12
What explains the decline in adolescent binge-drinking in New Zealand?	12
Evidence that social-economic factors play an important role in drug overdose deaths	12
The effect of injecting alone on the use of drug checking services among people who inject drugs	12
Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapy	12
Predictors of work engagement among Australian non-government drug and alcohol employees: Implications for policy and practice	12
Evidence-making hepatitis C cure: Towards a science that knows more carefully	11
Co-creating a social science research agenda for clean sport: An international Delphi study	11
Pharmacosex: Reimagining sex, drugs and enhancement	11
Young people's use of e-cigarettes in Wales, England and Scotland before and after introduction of EU Tobacco Products Directive regulations: a mixed-method natural experimental evaluation	11
Seeking legitimacy for broad understandings of substance use	11
Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island	11
Visitors of the Dutch drug checking services: Profile and drug use experience	11
The success rate of online illicit drug transactions during a global pandemic	11
Overview of “home” cultivation policies and the case for community-based cannabis supply	11
Problematic alcohol use among fathers in Kenya: Poverty, people, and practices as barriers and facilitators to help acceptance	11
“Is it banned? Is it illegal?”: Navigating Western Australia's regulatory environment for e-cigarettes	11
Hospital policy as a harm reduction intervention for people who use drugs	11
United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006–2020	11
Attitudes towards Kratom use, decriminalization and the development of a community-based Kratom control mechanism in Southern Thailand	11
Imagining a fentanyl future: Some consequences of synthetic opioids replacing heroin	11
E-cigarette use is associated with susceptibility to tobacco use among Australian young adults	11
Uncertainty and risk: A framework for understanding pricing in online drug markets	11
Naloxone distribution, trauma, and supporting community-based overdose responders	11
Taking opioids in times of crisis: Institutional oversight, chronic pain and suffering in an integrated healthcare delivery system in the U.S.	11
Self-reported driving after marijuana use in association with medical and recreational marijuana policies	11
Perceived vulnerability to overdose-related arrests among people who use drugs in Maryland	11
Medicinal cannabis and driving: the intersection of health and road safety policy	11
Effectiveness of a school-based substance use prevention program taught by police officers in Brazil: Two cluster randomized controlled trials of the PROERD	11
A randomized pilot study assessing the acceptability of rapid point-of-care hepatitis C virus (HCV) testing among male inmates in Montreal, Canada	11
US drug overdose mortality: 2009–2018 increases affect young people who use drugs	11
Perceived Importance of Factors in Cannabis Purchase Decisions: A Best-worst Scaling Experiment	11
Trajectories of alcohol use problems based on early adolescent alcohol use: Findings from a 35 year population cohort	11
Association of alcohol control policies with adolescent alcohol consumption and with social inequality in adolescent alcohol consumption: A multilevel study in 33 countries and regions	11
Beyond a ‘post-cure’ world: Sketches for a new futurology of hepatitis C	11
Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysis	11
Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting	11
Drug induced homicide laws may worsen opioid related harms: An example from rural North Carolina	11
Sisters are never alike? Drug control intensity in the Nordic countries	11
Opioids, stimulants, and depressant drugs in fifteen Mexican Cities: A wastewater-based epidemiological study	11
Risk and enabling environments in sport: Systematic doping as harm reduction	11
A free mailed naloxone program in Philadelphia amidst the COVID-19 pandemic	11
The Philippines’ antidrug campaign: Spatial and temporal patterns of killings linked to drugs	11
The practice and embodiment of “goofballs”: A qualitative study exploring the co-injection of methamphetamines and opioids	11
Rurality and differences in pharmacy characteristics and community factors associated with provision of naloxone in the pharmacy	11